KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Evolent Health (EVH) Return on Capital Employed (2016 - 2026)

Evolent Health has reported Return on Capital Employed over the past 11 years, most recently at 22.9% for Q4 2025.

  • For Q4 2025, Return on Capital Employed fell 2066.0% year-over-year to 22.9%; the TTM value through Dec 2025 reached 22.9%, down 2066.0%, while the annual FY2025 figure was 22.33%, 2020.0% down from the prior year.
  • Return on Capital Employed for Q4 2025 was 22.9% at Evolent Health, down from 1.01% in the prior quarter.
  • Over five years, Return on Capital Employed peaked at 0.27% in Q4 2022 and troughed at 27.45% in Q1 2021.
  • A 5-year average of 4.5% and a median of 2.39% in 2023 define the central range for Return on Capital Employed.
  • Biggest five-year swings in Return on Capital Employed: soared 2452bps in 2022 and later tumbled -2066bps in 2025.
  • Year by year, Return on Capital Employed stood at 4.76% in 2021, then skyrocketed by 106bps to 0.27% in 2022, then crashed by -1424bps to 3.56% in 2023, then skyrocketed by 37bps to 2.24% in 2024, then plummeted by -922bps to 22.9% in 2025.
  • Business Quant data shows Return on Capital Employed for EVH at 22.9% in Q4 2025, 1.01% in Q3 2025, and 1.88% in Q2 2025.